Clinical Investigation of the Clareon® Intraocular Lens (IOL)

NACompletedINTERVENTIONAL
Enrollment

376

Participants

Timeline

Start Date

July 25, 2017

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2019

Conditions
Cataract
Interventions
DEVICE

Clareon aspheric hydrophobic acrylic monofocal IOL

Ultraviolet-absorbing and blue light-filtering IOL composed of high refractive-index foldable and flexible acrylic material. IOLs are implantable medical devices intended for long term use over the lifetime of the cataract subject.

Trial Locations (16)

10013

Alcon Investigative Site, New York

12603

Alcon Investigative Site, Poughkeepsie

27909

Alcon Investigative Site, Elizabeth City

28387

Alcon Investigative Site, Southern Pines

29456

Alcon Investigative Site, Ladson

29501

Alcon Investigative Site, Florence

33064

Alcon Investigative Site, Deerfield Beach

48302

Alcon Investigative Site, Bloomfield Hills

54914

Alcon Investigative Site, Appleton

60467

Alcon Investigative Site, Orland Park

64154

Alcon Investigative Site, Kansas City

75965

Alcon Investigative Site, Nacogdoches

78731

Alcon Investigative Site, Austin

93720

Alcon Investigative Site, Fresno

94578

Alcon Investigative Site, San Leandro

95815

Alcon Investigative Site, Sacramento

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY